Christie Ballantyne
Christie Ballantyne
Dirección de correo verificada de bcm.edu
Título
Citado por
Citado por
Año
Heart disease and stroke statistics—2012 update: a report from the American Heart Association
Writing Group Members, VL Roger, AS Go, DM Lloyd-Jones, EJ Benjamin, ...
Circulation 125 (1), e2-e220, 2012
40982*2012
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I
M Naghavi, P Libby, E Falk, SW Casscells, S Litovsky, J Rumberger, ...
Circulation 108 (14), 1664-1672, 2003
43212003
Antiinflammatory therapy with canakinumab for atherosclerotic disease
PM Ridker, BM Everett, T Thuren, JG MacFadyen, WH Chang, ...
New England journal of medicine 377 (12), 1119-1131, 2017
40742017
Biological, clinical and population relevance of 95 loci for blood lipids
TM Teslovich, K Musunuru, AV Smith, AC Edmondson, IM Stylianou, ...
Nature 466 (7307), 707-713, 2010
33692010
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial
SE Nissen, SJ Nicholls, I Sipahi, P Libby, JS Raichlen, CM Ballantyne, ...
Jama 295 (13), 1556-1565, 2006
27852006
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial)
PH Jones, MH Davidson, EA Stein, HE Bays, JM McKenney, E Miller, ...
The American journal of cardiology 92 (2), 152-160, 2003
19132003
Effects of dalcetrapib in patients with a recent acute coronary syndrome
GG Schwartz, AG Olsson, M Abt, CM Ballantyne, PJ Barter, J Brumm, ...
New England Journal of Medicine 367 (22), 2089-2099, 2012
18882012
Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities …
SJ Hwang, CM Ballantyne, AR Sharrett, LC Smith, CE Davis, AM Gotto Jr, ...
Circulation 96 (12), 4219-4225, 1997
17941997
Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association
M Miller, NJ Stone, C Ballantyne, V Bittner, MH Criqui, HN Ginsberg, ...
Circulation 123 (20), 2292-2333, 2011
17722011
The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study
AM McNeill, WD Rosamond, CJ Girman, SH Golden, MI Schmidt, HE East, ...
Diabetes care 28 (2), 385-390, 2005
14032005
Efficacy and safety of evolocumab in reducing lipids and cardiovascular events
MS Sabatine, RP Giugliano, SD Wiviott, FJ Raal, DJ Blom, J Robinson, ...
New England Journal of Medicine 372 (16), 1500-1509, 2015
13612015
Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia
DL Bhatt, PG Steg, M Miller, EA Brinton, TA Jacobson, SB Ketchum, ...
New England Journal of Medicine 380 (1), 11-22, 2019
13452019
Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein (a), apolipoproteins AI and B, and HDL density subfractions: The …
AR Sharrett, CM Ballantyne, SA Coady, G Heiss, PD Sorlie, D Catellier, ...
Circulation 104 (10), 1108-1113, 2001
11522001
Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study
BB Duncan, MI Schmidt, JS Pankow, CM Ballantyne, D Couper, A Vigo, ...
Diabetes 52 (7), 1799-1805, 2003
10512003
Comprehensive overview of nursing and interdisciplinary rehabilitation care of the stroke patient: a scientific statement from the American Heart Association
EL Miller, L Murray, L Richards, RD Zorowitz, T Bakas, P Clark, ...
Stroke 41 (10), 2402-2448, 2010
1039*2010
Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study
V Nambi, L Chambless, AR Folsom, M He, Y Hu, T Mosley, K Volcik, ...
Journal of the American College of Cardiology 55 (15), 1600-1607, 2010
10202010
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association
MA Hlatky, P Greenland, DK Arnett, CM Ballantyne, MH Criqui, ...
Circulation 119 (17), 2408-2416, 2009
10052009
Effect of two intensive statin regimens on progression of coronary disease
SJ Nicholls, CM Ballantyne, PJ Barter, MJ Chapman, RM Erbel, P Libby, ...
New England Journal of Medicine 365 (22), 2078-2087, 2011
8902011
Lipoprotein-Associated Phospholipase A2, High-Sensitivity C-Reactive Protein, and Risk for Incident Coronary Heart Disease in Middle-Aged Men and Women in …
CM Ballantyne, RC Hoogeveen, H Bang, J Coresh, AR Folsom, G Heiss, ...
Circulation 109 (7), 837-842, 2004
8542004
Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial
CM Ballantyne, J Houri, A Notarbartolo, L Melani, LJ Lipka, R Suresh, ...
Circulation 107 (19), 2409-2415, 2003
8382003
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20